This is a series of guidance for clinical trial sites, supporting considerations for participant data sharing, restarting of trials by trial management teams, amd undertaking COVID19 contingency planning.
Please click here for more information.
We have placed cookies on your computer to help make this website better. For more information please click here
By continuing to use this site or closing this panel, we'll assume you're OK to continue. You can view our full privacy policy here